5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/II study of dose-dense sequential chemotherapy in renal impaired patients (Pts) with transitional cell carcinoma (TCC) of the urothelium
    Meeting Abstract

    Galsky, M. D.; Mironov, S.; Scattergood, J.; Dobrzynski, D.; Mitra, N.; Boyle, M. G.; Bajorin, D. F.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A phase I dose escalation trial of pulsatile high dose gefitinib and docetaxel in patients with an advanced solid tumor
    Meeting Abstract

    Fury, M. G.; Kris, M.; Solit, D.; Pfister, D. G.; Azzoli, C. G.; Henry, R.; Su, Y. B.; Rizvi, N.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Association of age, baseline characteristics, co-marbidity and toxicity in castrate metastatic prostate cancer patients (CMPC) treated with chemotherapy
    Meeting Abstract

    Fleming, M. T.; Beekman, K. W.; Warren, M.; Wilton, A.; Heller, G.; Scher, H.; Kelly, W. K.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Evaluation of plasma insulin-like growth factor binding protein 2 (IGFBP-2) as a biomarker for 17-allylamino-17-demethoxygeldanamycin (17-AAG) treatment of adult patients (pts) with advanced solid tumors
    Meeting Abstract

    Eiseman, J. L.; Guo, J.; Weinbaum, B.; Ramanathan, R. K.; Belani, C. P.; Solit, D. B.; Scher, H. I.; Ivy, S. P.; Zuhowski, E. G.; Egorin, M. J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Optimal combined modality treatment improves outcome of locally advanced bladder cancer: Analysis of SWOG 8710
    Meeting Abstract

    Dotan, Z. A.; Bajorin, D. F.; Grossman, B. H.; Herr, H. W.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • The multitargeted kinase inhibitor sunitinib malate (SU11248): Soluble protein biomarkers of pharmacodynamic activity in patients with metastatic renal cell cancer
    Meeting Abstract

    DePrimo, S.; Bello, C.; Smeraglia, J.; Shalinsky, D.; Freddo, J.; Baum, C.; Rini, R.; Michaelson, M.; Motzer, R.; Spinella, D.
    EJC Supplements (2005)

    Fulltext@MSK | Save
  • A synthetic peptide, PCK3145, for the treatment of hormone refractory prostate cancer
    Meeting Abstract

    Daigneault, L.; Panchal, C.; Scher, H. I.; Slovin, S. F.; Rabbani, S.; Dulude, H.; Garde, S.; Ruiz, M.; Wu, J.; Hawkins, R.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Post-chemotherapy retroperitoneal lymph node dissection for non-seminomatous germ cell tumors: The impact of time
    Meeting Abstract

    Carver, B. S.; Motzer, R. J.; Bajorin, D.; Stasi, J.; Bosl, G. J.; Sheinfeld, J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Prognosis after androgen deprivation therapy in men with a rising PSA after prostatectomy
    Meeting Abstract

    Bianco, F. J.; Kattan, M. W.; Beekman, K. W.; Scher, H. I.; Scardino, P. T.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Outcomes with second-line chemotherapy in castrate metastatic prostate cancer
    Meeting Abstract

    Beekman, K. W.; Fleming, M. T.; Scher, H. I.; Warren, M.; Ishill, N.; Heller, G.; Kelly, W. K.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save